CA2837126A1 - Canine influenza recombinant virus, preparation method therefor and application thereof - Google Patents

Canine influenza recombinant virus, preparation method therefor and application thereof Download PDF

Info

Publication number
CA2837126A1
CA2837126A1 CA2837126A CA2837126A CA2837126A1 CA 2837126 A1 CA2837126 A1 CA 2837126A1 CA 2837126 A CA2837126 A CA 2837126A CA 2837126 A CA2837126 A CA 2837126A CA 2837126 A1 CA2837126 A1 CA 2837126A1
Authority
CA
Canada
Prior art keywords
virus
canine influenza
seq
recombinant virus
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2837126A
Other languages
English (en)
French (fr)
Inventor
Zejun Li
Qiaoyang TENG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Veterinary Research Institute
Original Assignee
Shanghai Veterinary Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Veterinary Research Institute filed Critical Shanghai Veterinary Research Institute
Publication of CA2837126A1 publication Critical patent/CA2837126A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
CA2837126A 2011-05-26 2012-04-26 Canine influenza recombinant virus, preparation method therefor and application thereof Abandoned CA2837126A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2011101395283A CN102220293B (zh) 2011-05-26 2011-05-26 犬流感重组病毒及其制备方法和应用
CN201110139528.3 2011-05-26
PCT/CN2012/074722 WO2012159522A1 (zh) 2011-05-26 2012-04-26 犬流感重组病毒及其制备方法和应用

Publications (1)

Publication Number Publication Date
CA2837126A1 true CA2837126A1 (en) 2012-11-29

Family

ID=44776999

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2837126A Abandoned CA2837126A1 (en) 2011-05-26 2012-04-26 Canine influenza recombinant virus, preparation method therefor and application thereof

Country Status (7)

Country Link
US (1) US20140286979A1 (enExample)
EP (1) EP2716752A4 (enExample)
JP (1) JP2014516530A (enExample)
KR (1) KR20140031912A (enExample)
CN (1) CN102220293B (enExample)
CA (1) CA2837126A1 (enExample)
WO (1) WO2012159522A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102220293B (zh) * 2011-05-26 2012-12-19 中国农业科学院上海兽医研究所 犬流感重组病毒及其制备方法和应用
CN103881983B (zh) * 2014-03-07 2016-08-31 中国农业科学院哈尔滨兽医研究所 重组犬流感病毒毒株、其制备方法及由其制备得到的疫苗
KR101633489B1 (ko) 2015-02-25 2016-06-27 고패스 주식회사 통풍수단이 구비된 신발의 사출식 제조방법
NZ739260A (en) 2015-06-26 2019-09-27 Boehringer Ingelheim Animal Health Usa Inc Inactivated canine influenza vaccines and methods of making and uses thereof
CN105647877A (zh) * 2016-02-02 2016-06-08 南京农业大学 一株低毒力重组猪脑心肌炎病毒及其应用
CN107602697B (zh) * 2017-08-29 2020-05-05 杭州医学院 一种治疗流感嗜血杆菌引起鼻窦炎的血清及该血清的应用
CN113173976B (zh) * 2021-06-03 2022-07-12 北京市农林科学院 一种犬流感病毒h3亚型ha蛋白、其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1820853T3 (da) * 1999-04-06 2011-12-19 Wisconsin Alumni Res Found Rekombinant influenzavirus til vacciner og genterapi
CN1261564C (zh) * 2003-12-02 2006-06-28 中国农业科学院哈尔滨兽医研究所 人工重组的流感病毒及其应用
US7384642B2 (en) * 2005-08-25 2008-06-10 Merial Limited Canine influenza vaccines
EP2407480B1 (en) * 2005-10-19 2014-07-16 University of Florida Research Foundation, Incorporated Materials for respiratory disease control in canines
MX2010002729A (es) * 2007-09-10 2010-03-31 Intervet Int Bv Composiciones y metodos para prevenir infeccion de influenza en caninos, felinos y equinos.
KR100850545B1 (ko) * 2007-10-30 2008-08-05 주식회사 에니멀제네틱스 신규한 개 인플루엔자 바이러스 및 이의 백신
CN102220293B (zh) * 2011-05-26 2012-12-19 中国农业科学院上海兽医研究所 犬流感重组病毒及其制备方法和应用

Also Published As

Publication number Publication date
US20140286979A1 (en) 2014-09-25
JP2014516530A (ja) 2014-07-17
CN102220293A (zh) 2011-10-19
CN102220293B (zh) 2012-12-19
KR20140031912A (ko) 2014-03-13
EP2716752A4 (en) 2014-04-30
EP2716752A1 (en) 2014-04-09
WO2012159522A1 (zh) 2012-11-29

Similar Documents

Publication Publication Date Title
US11542527B2 (en) Parainfluenza virus 5 based vaccines
CN115998856B (zh) 一种新冠流感免疫原性组合物及其制备方法和应用
JP6042131B2 (ja) イヌにおける呼吸器疾患管理のための材料および方法
US20140286979A1 (en) Canine influenza recombinant virus, preparation method therefor and application thereof
JP2009512449A (ja) イヌにおける呼吸器疾患管理のための材料および方法
Nogales et al. Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use
JP2014511119A (ja) Ｈ１ｎ１亜型インフルエンザパンデミックウイルスに対する新型ワクチン
CN106117369A (zh) 融合蛋白sHA1‑Fc及应用
CN105671002B (zh) H9n2亚型禽流感病毒细胞高产疫苗株构建及应用
CN104073470A (zh) 一种h9n2亚型禽流感病毒的转瓶培养方法
KR101908905B1 (ko) 인플루엔자 바이러스의 h9 및 h5의 다중 아형에 대한 교차 면역반응을 형성하는 신규한 재조합 인플루엔자 바이러스 및 이를 포함하는 백신
CN103881983B (zh) 重组犬流感病毒毒株、其制备方法及由其制备得到的疫苗
CN105087502B (zh) H9n2亚型禽流感病毒温度敏感性减毒活疫苗候选株ca‑28（ah）及其应用
JP2015506949A5 (enExample)
CN117659138B (zh) 一种流感病毒np蛋白突变体及其应用
JP6174857B2 (ja) 外来物質試験
CN115725517B (zh) 一种h3n2犬流感重组病毒株及其应用
US20260034205A1 (en) Modified live attenuated flu virus vaccines and uses thereof
Liang et al. Research of Recombinant Influenza A Virus as a Vector for Mycoplasma Pneumoniae P1a and P30a
CN102234636B (zh) 重组甲型H1N1流感病毒冷适应弱毒活疫苗株(SC/AAca)的制备及应用
HK1188736B (en) Extraneous agents testing
HK1188736A (en) Extraneous agents testing

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20131122

FZDE Discontinued

Effective date: 20160427